Informations techniques
Exploitant
THERATECHNOLOGIES INTERNATIONAL LIMITED
Présentation
TROGARZO 200 mg/1,33 mL (ibalizumab), solution pour perfusion
2 flacons de 1,33 mL (CIP : 34009 589 018 9 8)
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
pwGLughhq87Zgq4H